抗脂综合征中的IgM抗脂抗体:患病率,临床关联和诊断影响 - - 范围审查
Monika Očková1, Ariadna Anunciación-Llunell1, Catalina Andrada1
1Systemic Autoimmune Diseases Research Unit, Vall d'Hebron Institut de Recerca (VHIR), Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Journal of clinical medicine
|October 29, 2025
概括
在抗脂综合征 (APS) 中,IgM抗脂抗体 (aPL) 是普遍存在的,并且与妊娠丧失和血栓形成有关. 需要进一步的研究来澄清它们的临床意义和指导解释.
科学领域:
- 类风湿病学 类风湿病学
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 在2023年ACR/EULAR标准变化之后,IgM抗脂抗体 (aPL) 的作用尚不确定.
- 了解IgM aPL的临床意义对于抗脂综合征 (APS) 的诊断和管理至关重要.
研究的目的:
- 对IgM抗脂抗体 (aPL) 的流行率和临床关联进行快速范围审查.
- 评估IgM aCL,IgM aβ2GPI和IgM aPS/PT在各种临床环境中的重要性.
主要方法:
- 对PubMed (2000年1月至2025年6月) 进行了快速范围审查.
- 包括原始人类研究报告的IgM aCL,aβ2GPI或aPS/PT的流行或结果.
- 从40个符合条件的研究中提取了临床关联的流行数据和几率比率 (ORs).
主要成果:
- 在APS表型中,IgM aPL是常见的,其患病率通常与IgG相比.
- 值得注意的关联包括妊娠损失 (高位IgM aCL,aβ2GPI,aPS/PT),血栓形成 (aPS/PT) 和器官特异性动脉事件 (孤立的IgM表型).
- 患病率有所不同:IgM aCL (3-82%),IgM aβ2GPI (2-63%),IgM aPS/PT (31-79%在混合队列中,55-62%在血栓性队列中).
结论:
- 在APS中IgM抗脂抗体 (aPL) 的确切作用仍然不确定.
- 这些发现支持对IgM aPL的细微解释,主张在特定的临床场景中重新考虑.
- 强调进一步研究IgM aPL的机械和预后效用.
相关概念视频
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
346
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
346
Phosphoinositides and PIPs
10.1K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.1K
Endocarditis II: Clinical Features of Infective Endocarditis
405
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
405
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
455
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
455
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
284
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
284


